APPLICATIONS

Product Type

Quantifiables

Compatibility

Relevance

Trans – MSC

Apoptosis, Necrosis, Vacuolization, inflammatory Interleukins, LD50, Delayed-type hypersensitivity (DTH), mitogen- or antigen-stimulated lymphocyte proliferative responses, macrophage function, and primary antibody response to T-cell dependent antigen, alteration in proto-oncogenes of tumor suppressor gene mutation, gene mutations, pluripotency, multipotency, bipotency, unipotency, tumor inducing property, stem cell DNA damage, stem cell mutation, inflammatory cascade, tumor formation, drug distribution ratio

Acute mammalian toxicity
Chronic toxicity
Cell penetration tests
Receptor binding tests
Eye/Skin corrosion tests
Cytotoxicity/Cell function based invitro tests
Genotoxicity tests
Developmental toxicity tests
Potency tests

Contract Research Organizations

Toxicity testing labs

Pharma

Biotech R&D

Trans – HSC  

Hematotoxicity specific Colony Forming Units (of hematopoietic precursor cells of various types), Spreading properties of platelets, Blood cell metabolic or functional changes and their dose response relationships, Development of micronuclei, Of any chromosomal aberrations

 

Hematotoxicity tests
Pyrogenicity tests

Contract Research Organizations,

Toxicity testing labs,

Pharma,

Biotech R&D

Trans-TR-B

Breast cancer cells specific death, cell signalling related proto-genomics, Tumor shrinking tests, Patient derived xenografts (PDX)

N/A

Contract Research Organizations,

Pharma in Oncology R&D

Trans-TR-H&N

Head & Neck cancer cells specific death, cell signalling related proto-genomics, Tumor shrinking tests, Patient derived xenografts (PDX)

N/A

Contract Research Organizations,

Pharma in Oncology R&D

Trans-TR-C

Colon cancer cells specific death, cell signalling related proto-genomics, Tumor shrinking tests, Patient derived xenografts (PDX)

N/A

Contract Research Organizations,

Pharma in Oncology R&D

Trans-TR-O

Ovarian cancer cells specific death, cell signalling related proto-genomics, Tumor shrinking tests, Patient derived xenografts (PDX)

N/A

Contract Research Organizations,

Pharma in Oncology R&D

Transchymal™-UC

To build 3D organs, human tissue (trachea, heart, liver, bone) engineering

N/A

3D Bioprinting companies

Biotechs in Tissue engineering

Exosomes research companies

Transchymal™-DP

To build 3D neural network, 3D periodontum, 3D tooth, cornea

N/A

3D Bioprinting companies

Biotechs in Tissue engineering

Exosomes research companies

Transchymal™ -AD

To build 3D breast

N/A

3D Bioprinting companies

Biotechs in Tissue engineering

Exosomes research companies